Outcomes of a cohort of children with hemoglobinopathy receiving oral iron chelators for treatment of transfusional iron overload in Turkey: Results of 3-year follow-up study

Antmen, B.Karakaş, Z.Küpesiz, O. A.Şaşmaz, I.Kurtoğlu, E.Aydoğan, G.Salcıoğlu, Z.Oktay, G.Calışkan, U.Akın, M.Vergin, C.Unal, S.Kazancı, E. G.Ayhan, A. C.Gümrük, F.Tunc, B.İrken, G.Yıldırmak, Y.Güneş, Adalet MeralSöker, M.Birkent, A.Dağ, I.Patiroğlu, T.2024-08-122024-08-122015-06-010390-6078https://hdl.handle.net/11452/43874Bu çalışma, 11-14, Haziran 2015 tarihlerinde Vienna[Avusturya]’da düzenlenen 20. Congress of European-Hematology-Association Kongresi‘nde bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineHematologyOutcomes of a cohort of children with hemoglobinopathy receiving oral iron chelators for treatment of transfusional iron overload in Turkey: Results of 3-year follow-up studyMeeting Abstract000361204902241292292100